153 results
8-K
BTAI
BioXcel Therapeutics Inc
22 Apr 24
Regulation FD Disclosure
7:10am
“forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. We intend such forward-looking statements
8-K
EX-99.1
BTAI
BioXcel Therapeutics Inc
22 Apr 24
Regulation FD Disclosure
7:10am
Securities Litigation Reform Act of 1995 . BioXcel Therapeutics, Inc . (“BioXcel” or the “Company”) intends such forward - looking statements to be covered
8-K
EX-99.1
BTAI
BioXcel Therapeutics Inc
10 Apr 24
Regulation FD Disclosure
7:05am
includes “forward - looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 . BioXcel Therapeutics, Inc
8-K
dxzb28gbty
10 Apr 24
Regulation FD Disclosure
7:05am
8-K
5t4gr
25 Mar 24
Entry into a Material Definitive Agreement
4:05pm
8-K
EX-10.1
ww4kyut3fyr29i6sk4
25 Mar 24
Entry into a Material Definitive Agreement
4:05pm
8-K
EX-99.1
yradpkrhn4
12 Mar 24
BioXcel Therapeutics Reports Financial Results for the Fourth Quarter and Full Year 2023
7:15am
8-K
EX-99.1
hrxvcyejhxysm
14 Feb 24
Regulation FD Disclosure
7:00am
8-K
sfby0u97qogrpqqle2
8 Feb 24
Other Events
4:53pm
8-K
EX-10.1
nrl4mros2qk
8 Feb 24
Other Events
4:53pm
8-K
jlw3 bg337o
8 Feb 24
Other Events
7:08am
8-K
1m7l8pkw27 4e
12 Dec 23
Other Events
7:00am